Auditory event related potentials as tools to reveal cognitive late effects in childhood cancer patients

Clinical Neurophysiology

Volumn 122, Issue 1, 2011, Pages 62-72

  Järvelä, Liisa S ^a   Hurme, Saija ^b   Holopainen, Irma E ^a   Leino, Maria ^a,b   Hatanpää, Anne Mari ^b   Mikola, Hannu ^a   Kärki, Tarmo ^a   Salmi, Toivo T ^a   Lähteenmäki, Päivi M ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Acute lymphoblastic leukaemia; Childhood cancer; Cognitive; Late effect; MMN; P3a

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARITHMETIC; ARTICLE; AUDITORY STIMULATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; GERM CELL TUMOR; HOSPITALIZED CHILD; HUMAN; INTELLIGENCE QUOTIENT; LATENT PERIOD; MALE; MENTAL PERFORMANCE; MISMATCH NEGATIVITY; NEPHROBLASTOMA; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PHONETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ACOUSTIC STIMULATION; ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE OF TESTS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 78650173038     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2010.05.031     Document Type: Article

References (66)

1. Alderson A.L., Novack T.A. Neurophysiological and clinical aspects of glucocorticoids and memory: a review. J Clin Exp Neuropsychol 2002, 24:335-355.
2. Alho K., Woods D.L., Algazi A., Knight R.T., Naatanen R. Lesions of frontal cortex diminish the auditory mismatch negativity. Electroencephalogr Clin Neurophysiol 1994, 91:353-362.
3. Anderson F.S., Kunin-Batson A.S. Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatr Blood Cancer 2009, 52:159-164.
4. Bayley N. Bayley scales of infant development 1993, The Psychological Corporation, San Antonio. 2nd ed.
5. Bleyer W.A. Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 1981, 65(Suppl. 1):89-98.
6. Brown R.T., Sawyer M.B., Antoniou G., Toogood I., Rice M., Thompson N., et al. A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia. J Dev Behav Pediatr 1996, 17:392-398.
7. Buizer A.I., de Sonneville L.M., van den Heuvel-Eibrink M.M., Veerman A.J. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer 2005, 45:281-290.
8. Buizer A.I., de Sonneville L.M., Veerman A.J. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. Pediatr Blood Cancer 2009, 52:447-454.
9. Campbell L.K., Scaduto M., Sharp W., Dufton L., Van Slyke D., Whitlock J.A., et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2007, 49:65-73.
10. Carey M.E., Hockenberry M.J., Moore I.M., Hutter J.J., Krull K.R., Pasvogel A., et al. Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol 2007, 32:189-193.
11. Carey M.E., Haut M.W., Reminger S.L., Hutter J.J., Theilmann R., Kaemingk K.L. Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study. AJNR Am J Neuroradiol 2008, 29:792-797.
12. Cheour M., Haapanen M.L., Ceponiene R., Hukki J., Ranta R., Naatanen R. Mismatch negativity (MMN) as an index of auditory sensory memory deficit in cleft-palate and CATCH syndrome children. Neuroreport 1998, 9:2709-2712.
13. Cheour M., Leppanen P.H., Kraus N. Mismatch negativity (MMN) as a tool for investigating auditory discrimination and sensory memory in infants and children. Clin Neurophysiol 2000, 111:4-16.
14. Copeland D.R., Fletcher J.M., Pfefferbaum-Levine B., Jaffe N., Ried H., Maor M. Neuropsychological sequelae of childhood cancer in long-term survivors. Pediatrics 1985, 75:745-753.
15. Eiser C. Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation. Arch Dis Child 1978, 53:391-395.
16. Eiser C. Cognitive deficits in children treated for leukaemia. Arch Dis Child 1991, 66:164-168.
17. Forget H., Lacroix A., Somma M., Cohen H. Cognitive decline in patients with Cushing's syndrome. J Int Neuropsychol Soc 2000, 6:20-29.
18. Friedman D., Cycowicz Y.M., Gaeta H. The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neurosci Biobehav Rev 2001, 25:355-373.
19. Fu L., Talsma D., Baez F., Bonilla M., Moreno B., Ah-Chu M., et al. Measurement of health-related quality of life in survivors of cancer in childhood in Central America: feasibility, reliability, and validity. J Pediatr Hematol Oncol 2006, 28:331-341.
20. Grant J., Cranston A., Horsman J., Furlong W., Barr N., Findlay S., et al. Health status and health-related quality of life in adolescent survivors of cancer in childhood. J Adolesc Health 2006, 38:504-510.
21. Harila M.J., Winqvist S., Lanning M., Bloigu R., Harila-Saari A.H. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2009, 53:156-161.
22. Harila-Saari A.H., Vainionpaa L.K., Kovala T.T., Tolonen E.U., Lanning B.M. Nerve lesions after therapy for childhood acute lymphoblastic leukemia. Cancer 1998, 82:200-207.
23. Harila-Saari A.H., Huuskonen U.E., Tolonen U., Vainionpaa L.K., Lanning B.M. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials. Med Pediatr Oncol 2001, 36:345-351.
24. Harila-Saari A.H., Lähteenmäki P.M., Pukkala E., Kyyronen P., Lanning M., Sankila R. Scholastic achievements of childhood leukemia patients: a nationwide, register-based study. J Clin Oncol 2007, 25:3518-3524.
25. Heukrodt C., Powazek M., Brown W.S., Kennelly D., Imbus C., Robinson H., et al. Electrophysiological signs of neurocognitive deficits in long-term leukemia survivors. J Pediatr Psychol 1988, 13:223-236.
26. Holopainen I.E., Korpilahti P., Juottonen K., Lang H., Sillanpaa M. Attenuated auditory event-related potential (mismatch negativity) in children with developmental dysphasia. Neuropediatrics 1997, 28:253-256.
27. Holopainen I.E., Korpilahti P., Juottonen K., Lang H., Sillanpaa M. Abnormal frequency mismatch negativity in mentally retarded children and in children with developmental dysphasia. J Child Neurol 1998, 13:178-183.
28. Jansen N.C., Kingma A., Schuitema A., Bouma A., Huisman J., Veerman A.J., et al. Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: a prospective, sibling-controlled study. Eur J Cancer 2006, 42:2765-2772.
29. Jansen N.C., Kingma A., Schuitema A., Bouma A., Veerman A.J., Kamps W.A. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia. J Clin Oncol 2008, 26:3025-3030.
30. Kaipio M.L., Novitski N., Tervaniemi M., Alho K., Ohman J., Salonen O., et al. Fast vigilance decrement in closed head injury patients as reflected by the mismatch negativity (MMN). Neuroreport 2001, 12:1517-1522.
31. Kato M., Azuma E., Ido M., Ito M., Nii R., Higuchi K., et al. Ten-year survey of the intellectual deficits in children with acute lymphoblastic leukemia receiving chemoimmunotherapy. Med Pediatr Oncol 1993, 21:435-440.
32. Kemner C., Verbaten M.N., Koelega H.S., Buitelaar J.K., van der Gaag R.J., Camfferman G., et al. Event-related brain potentials in children with attention-deficit and hyperactivity disorder: effects of stimulus deviancy and task relevance in the visual and auditory modality. Biol Psychiatry 1996, 40:522-534.
33. Korinthenberg R., Igel B. Prospective neurophysiological study in children treated for acute lymphoblastic leukaemia: serial EEG during treatment and long-term follow up with evoked potentials. Eur J Pediatr 1990, 150:127-131.
34. Korpilahti P., Lang H.A. Auditory ERP components and mismatch negativity in dysphasic children. Electroencephalogr Clin Neurophysiol 1994, 91:256-264.
35. Krappmann P., Paulides M., Stohr W., Ittner E., Plattig B., Nickel P., et al. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up. Pediatr Hematol Oncol 2007, 24:101-109.
36. Light G.A., Swerdlow N.R., Braff D.L. Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci 2007, 19:1624-1632.
37. Lähteenmäki P.M., Holopainen I., Krause C.M., Helenius H., Salmi T.T., Heikki L.A. Cognitive functions of adolescent childhood cancer survivors assessed by event-related potentials. Med Pediatr Oncol 2001, 36:442-450.
38. Meadows A.T., Gordon J., Massari D.J., Littman P., Fergusson J., Moss K. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet 1981, 2:1015-1018.
39. Mennes M., Stiers P., Vandenbussche E., Vercruysse G., Uyttebroeck A., De Meyer G., et al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer 2005, 44:478-486.
40. Michaud K., Forget H., Cohen H. Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging. Brain Cogn 2009, 71:1-8.
41. Montour-Proulx I., Kuehn S.M., Keene D.L., Barrowman N.J., Hsu E., Matzinger M.A., et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. J Child Neurol 2005, 20:129-133.
42. Moore B.D., Copeland D.R., Ried H., Levy B. Neurophysiological basis of cognitive deficits in long-term survivors of childhood cancer. Arch Neurol 1992, 49:809-817.
43. Morr M.L., Shafer V.L., Kreuzer J.A., Kurtzberg D. Maturation of mismatch negativity in typically developing infants and preschool children. Ear Hear 2002, 23:118-136.
44. Näätänen R., Gaillard A.W., Mäntysalo S. Early selective-attention effect on evoked potential reinterpreted. Acta Psychol (Amst) 1978, 42:313-329.
45. Näätänen R., Alho K. Mismatch negativity - a unique measure of sensory processing in audition. Int J Neurosci 1995, 80:317-337.
46. Näätänen R. The mismatch negativity: a powerful tool for cognitive neuroscience. Ear Hear 1995, 16:6-18.
47. Näätänen R., Paavilainen P., Rinne T., Alho K. The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clin Neurophysiol 2007, 118:2544-2590.
48. Oeffinger K.C., Mertens A.C., Sklar C.A., Kawashima T., Hudson M.M., Meadows A.T., et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355:1572-1582.
49. Paakko E., Harila-Saari A., Vanionpaa L., Himanen S., Pyhtinen J., Lanning M. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr Oncol 2000, 35:456-461.
50. Peckham V.C., Meadows A.T., Bartel N., Marrero O. Educational late effects in long-term survivors of childhood acute lymphocytic leukemia. Pediatrics 1988, 81:127-133.
51. Peterson C.C., Johnson C.E., Ramirez L.Y., Huestis S., Pai A.L., Demaree H.A., et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008, 51:99-104.
52. Pogany L., Barr R.D., Shaw A., Speechley K.N., Barrera M., Maunsell E. Health status in survivors of cancer in childhood and adolescence. Qual Life Res 2006, 15:143-157.
53. Reddick W.E., Glass J.O., Helton K.J., Langston J.W., Xiong X., Wu S., et al. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol 2005, 26:1263-1269.
54. Reddick W.E., Shan Z.Y., Glass J.O., Helton S., Xiong X., Wu S., et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006, 106:941-949.
55. Reddick W.E., Laningham F.H., Glass J.O., Pui C.H. Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia. Neuroradiology 2007, 49:889-904.
56. Reddick W.E., Glass J.O., Johnson D.P., Laningham F.H., Pui C.H. Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia. AJNR Am J Neuroradiol 2009, 30:1947-1954.
57. Sato T., Miyao M., Muchi H., Gunji Y., Iizuka A., Yanagisawa M. P300 as indicator of effects of prophylactic cranial radiation. Pediatr Neurol 1992, 8:130-132.
58. Shafer V.L., Morr M.L., Kreuzer J.A., Kurtzberg D. Maturation of mismatch negativity in school-age children. Ear Hear 2000, 21:242-251.
59. Simoens V.L., Istok E., Hyttinen S., Hirvonen A., Naatanen R., Tervaniemi M. Psychosocial stress attenuates general sound processing and duration change detection. Psychophysiology 2007, 44:30-38.
60. Twaddle V., Britton P.G., Craft A.C., Noble T.C., Kernahan J. Intellectual function after treatment for leukaemia or solid tumours. Arch Dis Child 1983, 58:949-952.
61. Uberall M.A., Haupt K., Meier W., Hertzberg H., Beck J.D., Wenzel D. P300 abnormalities in long-time survivors of acute lymphoblastic leukemia in childhood - side effects of CNS prophylaxis?. Neuropediatrics 1996, 27:130-135.
62. Ueberall M.A., Wenzel D., Hertzberg H., Langer T., Meier W., Berger-Jones K., et al. CNS late effects after ALL therapy in childhood. Part II: conventional EEG recordings in asymptomatic long-term survivors of childhood ALL - an evaluation of the interferences between neurophysiology, neurology, psychology, and CNS morphology. German Late Effects Working Group. Med Pediatr Oncol 1997, 29:121-131.
63. Walhovd K.B., Fjell A.M., Reinvang I., Lundervold A., Fischl B., Salat D., et al. Cortical volume and speed-of-processing are complementary in prediction of performance intelligence. Neuropsychologia 2005, 43:704-713.
64. Wechsler D. Wechsler adult intelligence scale - revised 1981, The Psychological Corporation, New York, [Finnish translation: Helsinki, Psykologien Kustannus Oy; 1992].
65. Wechsler D. Wechsler preschool and primary scale of intelligence - revised 1990, The Psychological Corporation, Sidcup, [Finnish translation: Helsinki, Psykologien Kustannus Oy; 1995].
66. Wechsler D. Wechsler intelligence scale for children 1991, The Psychological Corporation, Sidcup, [Finnish translation: Helsinki, Psykologien Kustannus Oy; 1999]. 3rd ed.